Alternatives to Alto Neuroscience

Biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.

Developing novel therapeutics to restore gut lymphatic function.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

AI-powered platform for antibody discovery and development to create new medicines.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Canadian company operating in the legal psilocybin industry, focusing on cultivation, production, and distribution of psilocybin products.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

A global oncology company developing and commercializing innovative cancer treatments.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company focused on developing treatments for rare metabolic diseases.